Updated Jul 16, 2026 · Last SEC filing 2026-07-13
Edwards Lifesciences Corp (EW) has filed 36 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-13. 3 Form 8-K material event filings were reported by EW in the last 90 days. 9 Form 144 notices of proposed sale were filed for EW stock. InsiderAlpha tracks every EW SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001099800 |
|---|
| Form 4 filings (90d) | 36 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Form 144 notices (90d) | 9 |
| Latest Form 4 filing | 2026-07-13 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Bruls Annette | CVP, EMEACLA | F — Tax withholding / forfeiture | 109 | $92.21 | $10K | SEC | |
| Lippis Daniel J. | CVP, TAVR | S — Open-market sale | 619 | $91.70 | $57K | SEC | |
| Lippis Daniel J. | CVP, TAVR | M — Option exercise | 619 | $72.68 | $45K | SEC | |
| Mistras Theodora | CVP, Chief Financial Officer | A — Grant or award | 87.6K | $0.00 | — | SEC | |
| Mistras Theodora | CVP, Chief Financial Officer | A — Grant or award | 12.3K | $0.00 | — | SEC | |
| Lippis Daniel J. | CVP, TAVR | F — Tax withholding / forfeiture | 377 | $95.18 | $36K | SEC | |
| Lippis Daniel J. | CVP, TAVR | M — Option exercise | 619 | $72.68 | $45K | SEC | |
| Lippis Daniel J. | CVP, TAVR | S — Open-market sale | 619 | $91.40 | $57K | SEC | |
| Zovighian Bernard J | CEO | S — Open-market sale | 523 | $87.92 | $46K | SEC | |
| Dahl Andrew M. | SVP, Corporate Controller | S — Open-market sale | 568 | $86.08 | $49K | SEC | |
| BOBO DONALD E JR | CVP,Strategy/Corp Development | S — Open-market sale | 23.1K | $86.42 | $2.00M | SEC | |
| Chopra Daveen | CVP, TMTT & Surgical | S — Open-market sale | 1.5K | $84.60 | $127K | SEC | |
| Lippis Daniel J. | CVP, TAVR | S — Open-market sale | 620 | $81.14 | $50K | SEC | |
| Lippis Daniel J. | CVP, TAVR | M — Option exercise | 620 | $72.68 | $45K | SEC | |
| BOBO DONALD E JR | CVP,Strategy/Corp Development | S — Open-market sale | 10.0K | $82.07 | $818K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Edwards Lifesciences Corp (EW). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Lippis Daniel J. | 24 | $739K |
| Zovighian Bernard J | 13 | $881K |
| BOBO DONALD E JR | 12 | $4.26M |
| Chopra Daveen | 10 | $904K |
| Ullem Scott B. | 9 | $2.88M |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in EW insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live EW dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.